Oruka Therapeutics, Inc. SEC filings ORKA
Oruka Therapeutics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jun 26, 2009. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 17, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 18, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 6, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Jul 24, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 1, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Dec 19, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 24, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 14, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 18, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Feb 18, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Feb 27, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 22, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Mar 21, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Mar 17, 2016 | Dec 31, 2015 |
| 10-K | Annual report | Mar 19, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Mar 20, 2014 | Dec 31, 2013 |
| 10-K/A | Amended annual report | Apr 18, 2013 | Dec 31, 2012 |
| 10-K | Annual report | Mar 21, 2013 | Dec 31, 2012 |
| 10-K | Annual report | Mar 27, 2012 | Dec 31, 2011 |
| 10-K | Annual report | Mar 9, 2011 | Dec 31, 2010 |
| 10-K | Annual report | Mar 4, 2010 | Dec 31, 2009 |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ORKA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Menlo Park, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 907654
- Former names
- ARCA biopharma, Inc. (until Aug 30, 2024); NUVELO INC (until Jan 27, 2009); HYSEQ INC (until Jan 28, 2003)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.